Singapore markets closed

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
45.53+1.33 (+3.01%)
At close: 04:00PM EDT
45.53 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.37B
Enterprise value 2.90B
Trailing P/E 21.09
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)527.64
Price/book (mrq)5.38
Enterprise value/revenue 532.37
Enterprise value/EBITDA -8.50

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 389.63%
S&P500 52-week change 322.36%
52-week high 353.92
52-week low 318.00
50-day moving average 347.59
200-day moving average 334.40

Share statistics

Avg vol (3-month) 31.14M
Avg vol (10-day) 3829k
Shares outstanding 574.06M
Implied shares outstanding 674.06M
Float 868.05M
% held by insiders 12.24%
% held by institutions 1107.55%
Shares short (15 Apr 2024) 410.54M
Short ratio (15 Apr 2024) 413.07
Short % of float (15 Apr 2024) 417.24%
Short % of shares outstanding (15 Apr 2024) 414.24%
Shares short (prior month 15 Mar 2024) 411.17M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,807.66%

Management effectiveness

Return on assets (ttm)-31.62%
Return on equity (ttm)-54.90%

Income statement

Revenue (ttm)5.45M
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -341.35M
Net income avi to common (ttm)-325.1M
Diluted EPS (ttm)-5.15
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)479.2M
Total cash per share (mrq)6.5
Total debt (mrq)7.06M
Total debt/equity (mrq)1.13%
Current ratio (mrq)6.41
Book value per share (mrq)8.53

Cash flow statement

Operating cash flow (ttm)-222.8M
Levered free cash flow (ttm)-113.19M